Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|10|6|596-607

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.10, Iss.6, 2010-08, pp. : 596-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA-G and MIC expression in tumors and their role in anti-tumor immunity

By Seliger B.   Abken H.   Ferrone S.  

Trends in Immunology, Vol. 24, Iss. 2, 2003-02 ,pp. : 82-87

Elsevier

Access to resources Recommend Favorite

New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus

By Klupp J.   Dambrin C.   Regieli J.   van Gelder T.   Shorthouse R.   Morris R.E.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2172-2172

Elsevier

Access to resources Recommend Favorite

Multiplexed Fluorescence Imaging of Tumor Biomarkers in Gene Expression and Protein Levels for Personalized and Predictive Medicine

By  

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 1017-1023

Bentham Science Publishers

Access to resources Recommend Favorite

Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy

By Chen H-W.  

International Immunology, Vol. 15, Iss. 3, 2003-03 ,pp. : 427-435

Oxford University Press

Access to resources Recommend Favorite

Comparison of the Anti-Tumor Effects of Various Whole-Body Hyperthermia Protocols: Correlation with HSP 70 Expression and Composition of Splenic Lymphocytes

By Zhang Honghai   Wang Weirong   Zhang Shuhong   Huang Weida  

Immunological Investigations, Vol. 34, Iss. 3, 2005-08 ,pp. : 245-258

Informa Healthcare

Access to resources Recommend Favorite